Literature DB >> 6884423

Disappearance and reappearance of high endothelial venules and immigrating lymphocytes in lymph nodes deprived of afferent lymphatic vessels: a possible regulatory role of macrophages in lymphocyte migration.

H R Hendriks, I L Eestermans.   

Abstract

Interruption of the afferent lymphatic vessels of the popliteal lymph node resulted in the disappearance of high endothelial venules (HEV) and immigrating lymphocytes within 3 weeks. HEV showed several characteristic morphological changes: the endothelial cells became flattened and less pyroninophilic, the chromatine became condensed and protein synthetizing and secretory cell organelles became scarce. At the same time the number of macrophages in the lymph node was severely reduced. Injection of sheep red blood cells into such lymph nodes, 6 weeks after operation, resulted in reappearance of HEV and immigrating lymphocytes, and development of many plasma cells and some germinal centres. Injection of lipopolysaccharide into the operated lymph nodes resulted in the appearance of many plasma cells and a few poorly developed germinal centres; HEV and immigrating lymphocytes, however, remained almost absent. The results show a relationship between the immigration of lymphocytes and the activity of the endothelial cells in the HEV. The activation of the latter may occur by mediators released by antigen-stimulated macrophages and T cells. Moreover, the morphological features of the HEV are independent of the presence of recirculating lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6884423     DOI: 10.1002/eji.1830130811

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  37 in total

1.  Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules.

Authors:  Christine Moussion; Jean-Philippe Girard
Journal:  Nature       Date:  2011-11-13       Impact factor: 49.962

2.  Interferon-gamma regulates an antigen specific for endothelial cells involved in lymphocyte traffic.

Authors:  A M Duijvestijn; A B Schreiber; E C Butcher
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  Central nervous system endothelial cell-polymorphonuclear cell interactions during autoimmune demyelination.

Authors:  A H Cross; C S Raine
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

Review 4.  Lymphatic function and immune regulation in health and disease.

Authors:  Shan Liao; Timothy P Padera
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

Review 5.  Lymphocyte migration to the gut: oversimplifications and controversial aspects.

Authors:  R Pabst
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

6.  A study on binding of suspended nodal lymphocytes to high endothelial venules in sections of frozen rat lymph nodes.

Authors:  G Sainte-Marie; F S Peng
Journal:  J Anat       Date:  1995-08       Impact factor: 2.610

7.  Splenic adherent cells, stimulated in vitro, induce the reactive formation of lymphoid follicles and germinal centres in draining lymph nodes after subcutaneous transfusion into syngeneic mice.

Authors:  K Tanaka; D Chen; S Negishi; S Aizawa; H Hoshi
Journal:  J Anat       Date:  1998-07       Impact factor: 2.610

Review 8.  Microvascular endothelial cell heterogeneity: interactions with leukocytes and tumor cells.

Authors:  P N Belloni; R J Tressler
Journal:  Cancer Metastasis Rev       Date:  1990-02       Impact factor: 9.264

9.  Interleukin 1 derived from human endothelial cells enhances the binding and chemotactic step of T lymphocyte emigration.

Authors:  P Miossec; D Cavender; M Ziff
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

10.  L-selectin and alpha 4 beta 7 integrin homing receptor pathways mediate peripheral lymphocyte traffic to AKR mouse hyperplastic thymus.

Authors:  S A Michie; P R Streeter; E C Butcher; R V Rouse
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.